Literature DB >> 30232997

Posterior reversible encephalopathy syndrome in eclampsia.

Ravindra K Garg1, Neeraj Kumar1, Hardeep S Malhotra1.   

Abstract

Posterior reversible encephalopathy syndrome is characterized by acute headache, visual impairment, seizures, and altered mental status; neuroimaging may show cerebral edema affecting the parietal and occipital lobes of the brain. The objective of this article is to review the current understanding of posterior reversible encephalopathy syndrome in eclampsia. Literature was searched from PubMed, Scopus, and Google Scholar databases. The search terms included "eclampsia", "eclampsia and posterior reversible encephalopathy syndrome", and "pregnancy and posterior reversible encephalopathy syndrome". We reviewed all published original articles with the search term "posterior reversible encephalopathy syndrome". Up to 100% of eclamptic patients may have reversible posterior leukoencephalopathy syndrome. Two putative mechanisms - "vasogenic" and "vasospasm" - are considered to be responsible. Cerebral edema and petechial cortical hemorrhages are common autopsy findings. Clinical and neuroimaging manifestations are reversible in the majority of patients. Prompt correction of increased blood pressure and treatment of seizures are the cornerstones of treatment. Magnesium sulfate is the drug of choice for seizures. Some survivors may have permanent vision loss and other disabling sequelae. In conclusion, posterior reversible encephalopathy is a devastating complication of eclampsia. Early recognition helps in preventing some of its devastating sequelae.

Entities:  

Keywords:  Epilepsy; hypertensive encephalopathy; magnetic resonance imaging; pregnancy

Mesh:

Year:  2018        PMID: 30232997     DOI: 10.4103/0028-3886.241364

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  8 in total

1.  Posterior Reversible Encephalopathy Syndrome in Women with Eclampsia-Report of Three Cases.

Authors:  Hiralal Konar; Lovely Agarwal; Priyadarshini Priyanka; Snehamay Chaudhuri
Journal:  J Obstet Gynaecol India       Date:  2021-01-02

2.  Case Report: Subacute Sclerosing Panencephalitis in Pregnancy Mimicking Posterior Reversible Encephalopathy Syndrome.

Authors:  Praveen Kumar Sharma; Ravindra Kumar Garg; Shinu Singla
Journal:  Am J Trop Med Hyg       Date:  2020-03       Impact factor: 2.345

3.  Atypical case of posterior reversible encephalopathy syndrome related to late onset postpartum eclampsia: A case report.

Authors:  Kaori Masai; Yayoi Ueda; Hiromichi Naito; Kohei Tsukahara; Toshiyuki Aokage; Noritomo Fujisaki; Hirotsugu Yamamoto; Atsunori Nakao
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

4.  Atypical Case of Posterior Reversible Encephalopathy in a Pregnant Patient Without Preeclampsia.

Authors:  Marvi Qureshi; Jeff Huang
Journal:  Cureus       Date:  2019-09-10

5.  Simultanagnosia as a cause of visual disturbance following Posterior Reversible Encephalopathy Syndrome (PRES): A case report.

Authors:  Niranjan K Pehere; Gordon N Dutton; Kshitij Mankad
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

6.  Posterior reversible encephalopathy syndrome induced by food poisoning in a pediatric patient: a case report.

Authors:  Xue-Mei Wu; Guang-Liang Wang; Chang-Gui Kou; Jiang-Tao Wang; Jian-Min Liang; Ya-Qin Yu
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

7.  An Unusual Presentation of Posterior Reversible Encephalopathy Syndrome Following Liver Transplantation.

Authors:  Akila Rajakumar; Susan Paulin; Dinesh Devarajan; Dinesh Jothimani; Shubha Subramanian; Srinivasan Kalyanasundaram; Mohamed Rela
Journal:  Transplant Direct       Date:  2022-01-05

8.  Posterior Reversible Encephalopathy Syndrome Is the Common Cause of New-Onset Seizures in the Peripartum Period: A Tertiary Hospital-Based Study in South India.

Authors:  Jagarlapudi Mk Murthy; Shyam K Jaiswal; Keshava Anand Gaade
Journal:  J Epilepsy Res       Date:  2021-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.